Skip to main content
Clinical Trials/NCT06751368
NCT06751368CompletedNot Applicable

Aortic Valve Regurgitation After Surgical Repair for Subaortic Stenosis in Children

Chinese Academy of Medical Sciences, Fuwai Hospital1 site in 1 country232 target enrollmentStarted: January 1, 2008Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
232
Locations
1
Primary Endpoint
Rate of Postoperative significant AR (SAR)

Study Overview

Brief Summary

Aortic valve regurgitation (AR) is a common complication following surgery for subaortic stenosis (SAS), yet the long-term outcomes and risk factors for postoperative significant AR (SAR) remain poorly understood. This study aims to investigate the incidence and risk factors of SAR in SAS patients and evaluate the long-term postoperative outcomes.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
0 Years to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age from 0-18
  • Clinical diagnosis of subaortic stenosis and underwent surgery

Exclusion Criteria

  • Diagnosed with hypertrophic cardiomyopathy
  • Underwent concomitant previous surgical repair for aortic valve or SAS
  • Follow-up time less than 1 year or lack of detailed information.

Outcomes

Primary Outcomes

Rate of Postoperative significant AR (SAR)

Time Frame: Through study completion, an average of 4 year

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Pan Xiangbin

Principal Investigator

Chinese Academy of Medical Sciences, Fuwai Hospital

Study Sites (1)

Loading locations...

Similar Trials